Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7617148, 6 pages
https://doi.org/10.1155/2017/7617148
Research Article

The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy

1Department of Urology, China Medical University Hospital, Taichung, Taiwan
2School of Medicine, China Medical University, Taichung, Taiwan
3Department of Radiology, China Medical University Hospital, Taichung, Taiwan
4Department of Pathology, School of Medicine, China Medical University, Taichung, Taiwan
5Department of Urology, China Medical University Beigang Hospital, Beigang, Yunlin, Taiwan

Correspondence should be addressed to Po-Fan Hsieh; wt.moc.oohay@melbuodhp

Received 7 March 2017; Revised 17 August 2017; Accepted 10 September 2017; Published 11 October 2017

Academic Editor: Michael Feuerstein

Copyright © 2017 Chao-Hsiang Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Heidenreich, P. J. Bastian, and J. Bellmunt, “EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013,” European Urology, vol. 65, no. 1, pp. 124–137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. N. E. Fleshner, M. O'Sullivan, and W. R. Fair, “Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate,” Journal of Urology, vol. 158, no. 2, pp. 505–509, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Babaian, A. Toi, K. Kamoi et al., “A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy,” Journal of Urology, vol. 163, no. 1, pp. 152–157, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. R. P. Kopp, S. P. Stroup, F. R. Schroeck et al., “Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database,” Journal of Urology, vol. 187, no. 6, pp. 2056–2060, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Scattoni, A. Zlotta, R. Montironi, C. Schulman, P. Rigatti, and F. Montorsi, “Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature,” European Urology, vol. 52, no. 5, pp. 1309–1322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. F. Shariat and C. G. Roehrborn, “Using biopsy to detect prostate cancer,” Reviews in Urology, vol. 10, no. 4, pp. 262–280, 2008. View at Google Scholar
  7. C. Maccagnano, A. Gallina, M. Roscigno et al., “Prostate saturation biopsy following a first negative biopsy: state of the art,” Urologia Internationalis, vol. 89, no. 2, pp. 126–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Akbal, P. Türker, H. H. Tavukçu, F. Şimşek, and L. Türkeri, “Erectile function in prostate cancer-free patients who underwent prostate saturation biopsy,” European Urology, vol. 53, no. 3, pp. 540–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. S. Jones, “Saturation biopsy for detecting and characterizing prostate cancer,” BJU International, vol. 99, no. 6, pp. 1340–1344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. I. G. Schoots, M. J. Roobol, D. Nieboer, C. Bangma, E. Steyerberg, and M. Hunink, “Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis,” European Urology, vol. 68, no. 3, pp. 438–450, 2015. View at Google Scholar
  11. M. De Rooij, E. H. J. Hamoen, J. J. Fütterer, J. O. Barentsz, and M. M. Rovers, “Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis,” American Journal of Roentgenology, vol. 202, no. 2, pp. 343–351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. C. P. Filson, S. Natarajan, D. J. A. Margolis et al., “Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies,” Cancer, vol. 122, no. 6, pp. 884–892, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Borkowetz, I. Platzek, M. Toma et al., “Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy,” BJU International, vol. 118, no. 2, pp. 213–220, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. J. P. Radtke, T. H. Kuru, S. Boxler et al., “Comparative Analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance,” The Journal of Urology, vol. 193, no. 1, pp. 87–94, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. N. L. Hansen, C. Kesch, T. Barrett et al., “Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy,” BJU International, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Pepe, A. Garufi, G. Priolo et al., “Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy,” Archivio Italiano di Urologia e Andrologia, vol. 86, no. 4, pp. 336–339, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. C. M. Moore, V. Kasivisvanathan, S. Eggener et al., “Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group,” European Urology, vol. 64, no. 4, pp. 544–552, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. O. Barentsz, J. Richenberg, R. Clements et al., “ESUR prostate MR guidelines 2012,” European Radiology, vol. 22, no. 4, pp. 746–757, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. I. Epstein, P. C. Walsh, M. Carmichael, and C. B. Brendler, “Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer,” JAMA: The Journal of the American Medical Association, vol. 271, no. 5, pp. 368–374, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. J. C. Weinreb, J. O. Barentsz, P. L. Choyke et al., “PI-RADS prostate imaging—reporting and data system: 2015, version 2,” European Urology, vol. 69, no. 1, pp. 16–40, 2016. View at Google Scholar
  21. B. Ehdaie, E. Vertosick, M. Spaliviero et al., “The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance,” Journal of Urology, vol. 191, no. 3, pp. 660–664, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. J. P. Radtke, C. Schwab, M. B. Wolf et al., “Multiparametric Magnetic Resonance Imaging (MRI) and MRI–transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen,” European Urology, vol. 70, no. 5, pp. 846–853, 2016. View at Google Scholar
  23. Y. H. Li, A. Elshafei, and J. Li, “Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen <10 ng/ml,” European Urology, vol. 65, no. 6, pp. 1178–1183, 2014. View at Publisher · View at Google Scholar
  24. A. W. Partin, L. A. Mangold, D. M. Lamm, P. C. Walsh, J. I. Epstein, and J. D. Pearson, “Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium,” Urology, vol. 58, no. 6, pp. 843–848, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Junker, M. Quentin, U. Nagele et al., “Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis,” World Journal of Urology, vol. 33, no. 7, pp. 1023–1030, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Pepe, M. Pennisi, and F. Fraggetta, “Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?” International Brazilian Journal of Urology, vol. 41, no. 5, pp. 844–848, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Ouzzane, P. Puech, L. Lemaitre et al., “Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading,” Urology, vol. 78, no. 6, pp. 1356–1362, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Cerantola, E. Haberer, J. Torres et al., “Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest,” World Journal of Urology, vol. 34, no. 1, pp. 75–82, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. J. S. Wysock, A. B. Rosenkrantz, W. C. Huang et al., “A prospective, blinded comparison of Magnetic Resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial,” European Urology, vol. 66, no. 2, pp. 343–351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Puech, O. Rouvière, R. Renard-Penna et al., “Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy—prospective multicenter study,” Radiology, vol. 268, no. 2, pp. 461–469, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. B. Rosenkrantz, S. Verma, P. Choyke et al., “Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR,” Journal of Urology, vol. 196, no. 6, pp. 1613–1618, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. J. C. Hu, E. Chang, S. Natarajan et al., “Targeted prostate biopsy in select men for active surveillance - Do the epstein criteria still apply?” Journal of Urology, vol. 192, no. 2, pp. 385–390, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Cash, K. Günzel, A. Maxeiner et al., “Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure,” BJU International, vol. 118, no. 1, pp. 35–43, 2016. View at Google Scholar